Correction: Müller et al. Does the Vaccination Against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates Below the WHO Threshold for Endemicity? A Case Study for Germany. Vaccines 2024, 12, 1165
Key Points
The aim is to correct previous findings regarding the cost-effectiveness of tick-borne encephalitis vaccination in Germany.
Correction of data errors in the cost-effectiveness analysis.
Review of incidence rates and vaccination costs.
Comparison against WHO guidelines for endemicity thresholds.
Clarified calculations indicate different value for money for vaccination rates.
Updated analysis suggests some incidence rates fall below recommended thresholds.
Abstract
The authors would like to make the following corrections to this published paper 1 ...
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Correction: Müller et al. Does the Vaccination Against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates Below the WHO Threshold for Endemicity? A Case Study for Germany. Vaccines 2024, 12, 1165 | Synapse